Guillaume Ploussard
University of Paris-Sud
CancerInternal medicineRadiologyUrologySurgeryMagnetic resonance imagingOncologyStage (cooking)Prospective cohort studyPathologicalBiopsyProstateBiochemical recurrenceDiseaseProstatectomyProstate cancerBladder cancerIn patientNephrologyMedicineCohort
110Publications
16H-index
662Citations
Publications 122
Newest
OBJECTIVE Annual countrywide data are scarce when comparing surgical approaches in terms of hospital stay outcomes and costs for radical prostatectomy (RP). We aimed to assess the impact of surgical approach on post-operative outcomes and costs after RP by comparing open (ORP), laparoscopic (LRP), and robot-assisted (RARP) RP in the French healthcare system. PATIENTS AND METHODS Data from all patients undergoing RP in France in 2020 were extracted from the central database of the national health...
Source
#4Eric BarretH-Index: 37
Abstract null null The evolution in the past decade of recommendations for prostate cancer (PCa) management, from screening to surgical treatment, may have affected the radical prostatectomy (RP) landscape. However, comprehensive data at a national level remain scarce. We extracted 5-yr data for RP patients in France from the central database of the national health care system. The primary endpoints were surgical approach (open [ORP], laparoscopic [LRP], and robot-assisted RP [RARP]), length of ...
Source
#7Gilles Crehange (Curie Institute)H-Index: 11
#8Raphaële Renard-Penna (University of Paris)H-Index: 9
Last. Charles Dariane (University of Paris)H-Index: 5
view all 15 authors...
Background: Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA for PCa theranostics in nuclear medicine that have already been tested in humans. Methods: We performed a systematic web search in the PubMed and Cochrane databases, with no time restrictions by pooling terms (“prostate cancer”, “prostatic neoplasms”...
Source
#1Igor Tsaur (University of Mainz)H-Index: 9
#2Maximilian Peter Brandt (University of Mainz)H-Index: 7
Last. Guillaume PloussardH-Index: 16
view all 5 authors...
Source
#1Simone Albisinni (ULB: Université libre de Bruxelles)H-Index: 17
#2R. Diamand (ULB: Université libre de Bruxelles)H-Index: 8
Last. Thierry Roumeguere (ULB: Université libre de Bruxelles)H-Index: 23
view all 34 authors...
Abstract null null Objectives null To evaluate whether continuing the antiplatelet drug acetylsalicylic acid≤100mg (ASA) during Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) increases the risk of peri-and postoperative hemorrhagic complications and overall morbidity. Indeed, guidelines recommend interrupting antiplatelet therapy before radical cystectomy; however, RARC with ICUD is associated to reduced estimated blood loss and blood transfusions compare...
Source
#7Thomas Hermanns (UZH: University of Zurich)H-Index: 29
Source
#1R.G. RahotaH-Index: 1
#2Guillaume PloussardH-Index: 16
Last. Ambroise SalinH-Index: 6
view all 10 authors...
Source
#1Cécile ManceauH-Index: 3
#2Gaëlle FromontH-Index: 28
Last. Romain MathieuH-Index: 25
view all 0 authors...
Active surveillance (AS) in prostate cancer (PCa) represents a curative alternative for men with localised low-risk PCa. Continuous improvement of AS patient’s selection and surveillance modalities aims at reducing misclassification, simplifying modalities of surveillance and decreasing need for invasive procedures such repeated biopsies. Biomarkers represent interesting tools to evaluate PCa diagnosis and prognosis, of which many are readily available or under evaluation. The aim of this review...
Source
#1R.G. RahotaH-Index: 1
#2R. Diamand (ULB: Université libre de Bruxelles)H-Index: 8
Last. Simone Albisinni (ULB: Université libre de Bruxelles)H-Index: 17
view all 11 authors...
Objective null To assess the whole pathology spectrum of Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions, identified on magnetic resonance imaging, using systematic (SB), targeted biopsy (TB) and radical prostatectomy (RP) specimen analysis. null Methods null From a prospective database of patients undergoing RP after a combination of SB (median 12 cores) and fusion TB (median 3 cores), we included 150 PI-RADS 3 cases. Clinically significant prostate cancer (csPCa) was defined by ...
Source
#1Igor TsaurH-Index: 23
#2Isabel Heidegger (Innsbruck Medical University)H-Index: 19
Last. Eliott Debedde (Paris V: Paris Descartes University)
view all 24 authors...
BACKGROUND Docetaxel (D) or secondary hormonal therapy (SHT) each combined with androgen deprivation therapy (ADT) represent possible treatment options in males with metastasized hormone-sensitive prostate cancer (mHSPC). Real-world data comparing different protocols are lacking yet. Thus, our objective was to compare the efficacy and safety of abiraterone acetate (AA)+ADT versus D+ADT in mHSPC. METHODS In a retrospective multicenter analysis including males with mHSPC treated with either of the...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.